SI

SHOULDER INNOVATIONS, INC.
—

Company Information

Company Name
SHOULDER INNOVATIONS, INC.
CIK
CIK0001699350
Category
<br>Emerging growth company
Ticker: Exchange
SI: NYSE
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
SI

SEC filing data through

Insider Sentiment

Last purchase
2026-03-13
Last sale
2026-09-14
Shares purchased (TTM)
10,105
Shares sold (TTM)
152,323
Buy ratio (TTM)6.2%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
8,358,761
Shares outstanding
20,735,694
Ownership
40.31%

Earnings Market Reaction

Filing date
2026-08-06
Price on filing date
—
1-month reaction
-5.66%
3-month reaction
…
Drift continued2/4 (50%)
Faded / reversed2/4 (50%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value2411275527
Available For Sale Securities Debt Securities Current7597978213
Accounts Receivable Net Current1111877
Inventory Net2322221917
Prepaid Expense Current22221
Other Assets Current23115
Assets Current13714615716769
Property Plant And Equipment Net141413119
Operating Lease Right Of Use Asset00000
Other Assets Noncurrent0----
Intangible Assets Net Excluding Goodwill00000
Assets15216017017878
Liabilities Current
Accounts Payable Current66996
Operating Lease Liability Current00000
Accrued Liabilities Current76566
Liabilities Current1312141512
Liabilities Noncurrent
Warrants And Rights Outstanding--002
Long Term Debt Noncurrent1515151515
Other Liabilities Noncurrent00000
Liabilities Noncurrent1515151517
Liabilities2827293029
Stockholders Equity
Common Stock Value00000
Preferred Stock Value0000-
Additional Paid In Capital2402392382373
Retained Earnings Accumulated Deficit-116-106-97-90-81
Accumulated Other Comprehensive Income Loss Net Of Tax-0-0000
Temporary Equity Carrying Amount Attributable To Parent-000127
Stockholders Equity124133141148-78
Liabilities And Stockholders Equity15216017017878
Related Party01101
Seed Convertible Preferred Stock--000
Series A Preferred Stock--000
Series B Preferred Stock--000
Series C Preferred Stock--000
Series D Preferred Stock--000
Series E Preferred Stock----0
Temporary Equity Shares Outstanding--00236
Common Stock Par Or Stated Value Per Share0.000.000.000.000.00
Common Stock Shares Authorized730730730730730
Common Stock Shares Issued212121213
Shares Outstanding212121213
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.00
Preferred Stock Shares Authorized2020202020
Temporary Equity Shares Authorized----238
Temporary Equity Shares Issued----236
Preferred Stock Shares Issued0000-
Preferred Stock Shares Outstanding0000-

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

SHOULDER INNOVATIONS, INC. (SI) — SEC Financial Statements & Analysis

SHOULDER INNOVATIONS, INC. (SI) is a surgical & medical instruments & apparatus company, incorporated in DE. SHOULDER INNOVATIONS, INC. trades on NYSE as: SI. SHOULDER INNOVATIONS, INC. (SI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, SHOULDER INNOVATIONS, INC. carries a market cap of $420.52M, a P/E ratio of -10.59x, a P/B ratio of 3.38x, a P/S ratio of 5.99x, an enterprise value of $410.87M, and an EV/EBITDA multiple of -10.42x. On profitability, it posts a gross margin of 77.27%, an operating margin of -56.20%, a net margin of -56.56%, a Return on Equity (ROE) of -172.11%, a Return on Assets (ROA) of -34.54%, and a Return on Invested Capital (ROIC) of -308.00%. Per share, it reports EPS of $-1.91, diluted EPS of $-1.91, free cash flow per share of $-2.27, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 10.71x, a quick ratio of 8.74x, working capital of $124.58M, a debt-to-equity ratio of 0.22x, a debt ratio of 0.18, an interest coverage ratio of -27.96x, free cash flow of $-47.08M (TTM), and net debt of $-9.65M. Figures sourced from SEC EDGAR.

Market Cap
$420.52M
P/E TTM
-10.59x
EPS TTM
$-1.91
P/B TTM
3.38x
ROE TTM
-172.11%
ROA TTM
-34.54%
Debt To Equity
0.22x
Free Cash Flow TTM
$-47.08M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SHOULDER INNOVATIONS, INC. in?

SHOULDER INNOVATIONS, INC. (SI) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does SI trade on?

SHOULDER INNOVATIONS, INC. (SI) trades on the NYSE.

Where is SHOULDER INNOVATIONS, INC. incorporated?

SHOULDER INNOVATIONS, INC. is incorporated in DE.

When was SHOULDER INNOVATIONS, INC. (SI)'s most recent SEC filing?

SHOULDER INNOVATIONS, INC. (SI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.

What is SI's market cap?

SHOULDER INNOVATIONS, INC. (SI) has a market capitalization of $420.52M as of 2026-06-30.

What is SI's EPS (earnings per share)?

SHOULDER INNOVATIONS, INC. (SI)'s trailing twelve month EPS is $-1.91 as of 2026-06-30.

What is SI's ROE (return on equity)?

SHOULDER INNOVATIONS, INC. (SI)'s trailing twelve month Return on Equity (ROE) is -172.11% as of 2026-06-30.

What is SI's ROA (return on assets)?

SHOULDER INNOVATIONS, INC. (SI)'s trailing twelve month Return on Assets (ROA) is -34.54% as of 2026-06-30.

What is SI's ROIC (return on invested capital)?

SHOULDER INNOVATIONS, INC. (SI)'s trailing twelve month Return on Invested Capital (ROIC) is -308.00% as of 2026-06-30.

What is SI's EV/EBITDA?

SHOULDER INNOVATIONS, INC. (SI)'s trailing twelve month EV/EBITDA is -10.42x as of 2026-06-30.

Wall Street's data.
Main Street's price.